Burden of Diabetes Prevalence.- Diabetes Drivers.- Impact of Diabetes Complications.- Cost-effectiveness of Available Diabetes Treatments.- Cost-effectiveness of Monitoring Metabolic Control.- Influence of Pharmaceutical Industry.- Promise of Nutrition.- Importance of Structured Diabetes Education.- Benefits of Centralized e-Health System in Diabetes C are.- Focus on Diabetes Prevention
Ivica Smokovski, MD, PhD is a certified Fellow (Sub-specialist) in Endocrinology, certified Specialist in Internal Medicine at University Clinic of Endocrinology, Diabetes and Metabolic Disorders Skopje, and Associate Professor at Faculty of Medical Sciences, University Goce Delcev Stip.
He has extensive experience in diabetes care from various perspectives and positions: as a clinician at University Clinic, as a Medical Adviser in pharmaceutical industry, and serving as a Medical Adviser for Diabetes Care to the Minister of Health for 4 years. He has been instrumental in instituting, and serving as a member, of the first National Diabetes Committee, a body for creating National Diabetes Policies, National Diabetes Care Guidelines, and monitoring of implementation of policies and guidelines. He has also been instrumental in forming of National e-Health System related to Diabetes Care in 2015, covering total population of the country across all three healthcare levels (primary, secondary, tertiary).
Prof Smokovski has published the State-of-the-Art article on Diabetes Care in Republic of Macedonia: Challenges and Opportunities, first comprehensive overview of the situation with diabetes in N Macedonia, estimated to have the second highest diabetes prevalence in Europe. In addition, he recently published the article on First stratified diabetes prevalence data for Republic of Macedonia derived from the National eHealth System, the first comprehensive diabetes data derived from the National e-Health System. He has been invited to lecture at numerous domestic and international diabetes medical events.
This book covers the complexity of diabetes and related complications and presents the socio-economic burden of the disease, taking into account the rising prevalence reaching pandemic proportions and the associated costs. Factors causing high diabetes prevalence and the influence of the pharmaceutical industry are evaluated and solutions for sustainable diabetes care with limited resources are provided, including national focus on providing cost-effective diabetes treatment, nutrition and physical activity, structured diabetes education and centralized National e-Health System. Moreover, elaboration of long-term efforts to curb the diabetes burden through prevention activities are presented in this book.
Managing Diabetes in Low Income Countries represents an essential guide for diabetes care clinicians and researchers, medical students and clinicians in training, diabetes policy makers, regulatory authorities, international diabetes and patient organisations all of whom are involved in current clinical practice for diabetes management.